Elissavet Kollia | Developmental Neuroscience |Best Researcher Award

Ms. Elissavet Kollia | Developmental Neuroscience |Best Researcher AwardĀ 

Ms. Elissavet Kollia, National Kapodistrian University of Athens, Greece.

Ms. Elissavet Kollia is a distinguished pediatrician and researcher specializing in pediatric neurology. With an exceptional academic background, she graduated from the Medical School of the Democritus University of Thrace and pursued advanced postgraduate studies in Clinical Pediatrics and Nursing-Research. Her extensive clinical training, from pediatrics specialization to her current role at Konstantopouleio General Hospital ā€œAgia Olga,ā€ has solidified her expertise in child healthcare. Additionally, her research focuses on movement disorders in pediatric patients with early-onset developmental and epileptic encephalopathy, contributing valuable insights to the field. Her dedication extends beyond clinical practice, as seen in her voluntary medical work and commitment to mentoring young professionals.

Profile

Google Scholar

šŸŽ“ Early Academic Pursuits

From an early age, Elissavet Kollia demonstrated exceptional academic abilities, graduating from the 4th General Lyceum of Agia Paraskevi with an outstanding general grade of “excellent 19.2.” Her passion for medicine led her to the Medical School of the Democritus University of Thrace, where she was admitted in September 2007. With dedication and perseverance, she successfully earned her medical degree in July 2013, achieving a commendable grade of “very good 8.33.” Shortly after, she obtained her license to practice as a doctor in Greece and later in Munich, Germany, reflecting her international medical competence.

šŸ„ Professional Endeavors

Ms. Kollia’s professional journey has been marked by extensive clinical training and hands-on experience in pediatrics. She began her specialization at the Pediatric Clinic of the General Hospital of Karpenisi from June 2014 to October 2016. Her commitment to healthcare extended beyond hospitals as she served as a rural doctor at the Primary Health Care Center of Agios Nikolaos, Evrytania, actively participating in emergency care at the General Hospital of Karpenisi. Her expertise deepened when she became a scientific associate at the Pediatric Neurology Unit of the First Pediatric Clinic of the National University of Athens. She then pursued her residency in pediatrics at the First University Pediatric Clinic – Children’s Hospital “Agia Sophia” from November 2018 to May 2022, ultimately obtaining her specialty title in June 2022. Currently, she is serving as a pediatrician at the Konstantopouleio General Hospital ā€œAgia Olga,ā€ continuing her mission to provide excellent pediatric care.

šŸ“ Contributions and Research Focus

Ms. Kollia’s dedication to medical research has significantly contributed to the field of pediatric neurology. Her postgraduate studies in “Clinical Pediatrics and Nursing-Research,” completed with an exceptional grade of “Excellent 9.31,” strengthened her academic foundation. Her ongoing doctoral dissertation at the National Kapodistrian University of Athens focuses on movement disorders in pediatric patients with early-onset developmental and epileptic encephalopathy, a field crucial for advancing neurological care in children. Her research efforts have led to an upcoming publication in the European Journal of Paediatric Neurology, further establishing her as a valuable contributor to the scientific community.

šŸŒŸ Accolades and Recognition

Ms. Kollia’s unwavering commitment to medicine has been recognized through her outstanding academic achievements and professional milestones. From excelling in her graduate and postgraduate studies to securing prestigious residency and specialization opportunities, she has consistently demonstrated excellence in her field. Her acceptance into renowned institutions and her involvement in vital research projects underline her credibility and expertise in pediatric neurology.

šŸ’Ŗ Impact and Influence

Beyond her clinical and academic contributions, Dr. Kollia has actively participated in voluntary medical programs, extending her expertise to underserved populations. She contributed to emergency case observations at the Children’s Hospital “Agia Sophia” and participated in medical landing programs in remote islands, showcasing her dedication to public health. Her influence extends to mentoring young medical professionals, sharing her knowledge, and contributing to the medical community’s growth.

šŸ’” Legacy and Future Contributions

With a passion for advancing pediatric neurology, Dr. Kollia continues to shape the future of medical research and patient care. Her work in understanding movement disorders in children with epileptic encephalopathy holds the potential to improve diagnostic and therapeutic approaches in pediatric neurology. As she progresses in her career, her contributions to both clinical practice and scientific research will undoubtedly leave a lasting impact on the medical community and the lives of the children she treats.

 

Publication

  • Title: The genetic etiology in cerebral palsy mimics: the results from a Greek tertiary care center
    Authors: V Zouvelou, D Yubero, L Apostolakopoulou, E Kokkinou, M Bilanakis, …
    Year: 2019

 

  • Title: MOTOR PHENOTYPING IN A GREEK COHORT OF PATIENTS WITH NEONATAL AND INFANTILE ONSET DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY
    Authors: E Kollia, E Kokkinou, C Outsika, G Koltsida, V Zouvelou, A Vontzalidis, …
    Year: 2025

 

šŸŒŸ Conclusion

Ms. Kolliaā€™s journey exemplifies the perfect blend of academic excellence, professional expertise, and compassionate patient care. Through her research and clinical endeavors, she continues to advance the understanding and treatment of pediatric neurological disorders. Her unwavering dedication to improving children’s health positions her as a leading figure in pediatric medicine. With her vision for excellence and continued contributions, she is set to leave a lasting impact on the medical field, inspiring future generations of healthcare professionals.

Pongrama Ramasoota | Molecular and Cellular Neuroscience | Best Researcher Award

Prof. Dr. Pongrama Ramasoota | Molecular and Cellular Neuroscience | Best Researcher Award

Prof. Dr. Pongrama Ramasoota, Mahidol University, Thailand.

Dr. Pongrama Ramasoota is a distinguished professor and researcher specializing in antibody research and virology at the Centre of Excellence for Antibody Research (CEAR), Mahidol University, Thailand. With a strong academic foundation in veterinary medicine, public health, and microbiology, he has dedicated his career to developing therapeutic and diagnostic monoclonal antibodies against viruses such as Dengue, Rabies, Foot and Mouth Disease, and Influenza. His contributions extend beyond infectious disease research, as he has also explored anti-aging supplements for humans and pets. Recognized with numerous national and international awards, his research has significantly impacted medical biotechnology, earning him a reputation as a leading scientist in his field.

 

Profile

Scopus

 

šŸŽ“ Early Academic Pursuits

Pongrama Ramasootaā€™s journey into the world of microbiology and antibody research began with a solid foundation in veterinary medicine. He earned his Doctor of Veterinary Medicine from Kasetsart University, where his fascination with infectious diseases and immunology took root. His academic pursuits led him to Mahidol University, where he obtained a Master of Public Health, further broadening his expertise in disease prevention and control. Driven by a passion for scientific exploration, he pursued a Master of Science and Ph.D. in Microbiology at the prestigious Swedish University of Agricultural Sciences in Uppsala, Sweden. These formative years were instrumental in shaping his career as a leading researcher in antibody development and disease management.

šŸ„ Professional Endeavors

As a distinguished professor at the Centre of Excellence for Antibody Research (CEAR) within the Faculty of Tropical Medicine, Mahidol University, Dr. Ramasoota has dedicated his career to advancing the field of immunotherapy. His research primarily focuses on developing neutralizing monoclonal antibodies to combat viral threats such as Dengue and Rabies. Over the years, he has led groundbreaking projects aimed at creating effective therapeutic and diagnostic solutions. His expertise has also extended beyond academia, as he collaborates with industry leaders to translate research into practical applications that benefit global health.

šŸ¦  Contributions and Research Focus

Dr. Ramasootaā€™s contributions to medical research are vast and impactful. His work on neutralizing human monoclonal antibodies against Dengue and Rabies viruses has paved the way for potential life-saving treatments. His research extends to diagnostic monoclonal antibodies for detecting Foot and Mouth Disease Virus (FMDV) and Influenza, significantly enhancing disease surveillance. Beyond infectious diseases, he has also ventured into anti-aging research, developing natural supplements to promote longevity in both humans and pets. His relentless pursuit of innovation continues to drive advancements in virology, immunotherapy, and biotechnology.

šŸ† Accolades and Recognition

Dr. Ramasootaā€™s contributions to science have been recognized with numerous prestigious awards. He was honored as Thailandā€™s Outstanding Researcher in 2020 and named Thailandā€™s Outstanding Veterinarian in 2016. His innovative work earned him multiple Outstanding Research and Invention Awards from the National Research Council of Thailand between 2008 and 2016. He has also received international recognition, including a gold medal from the 2014 Taipei Invention & Techno Mart and awards from the Korea Invention Association and the International Federation of Inventorsā€™ Associations. These accolades underscore his influence as a pioneer in antibody research and biotechnology.

šŸŒ Impact and Influence

With an H-index of 18 and over 1,038 citations on Scopus, Dr. Ramasootaā€™s research has significantly influenced the scientific community. His findings have been instrumental in shaping new treatment strategies for viral diseases, providing hope for better therapeutic interventions. Collaborating with industry leaders such as Advy Chemical (India) and Thai-Naoka (Thailand), he has helped bridge the gap between research and real-world applications. His contributions to diagnostic tools and monoclonal antibody therapies continue to shape the future of virology and medical biotechnology.

šŸ“š Legacy and Future Contributions

Beyond his research endeavors, Dr. Ramasoota has authored books that highlight his expertise in environmental management and anti-aging technologies. His book Hallmarks of Aging, Technology and Innovation for Anti-Aging explores groundbreaking advancements in longevity research, demonstrating his commitment to improving human health across various dimensions. As he continues to innovate, his legacy as a leading researcher in antibody development and viral immunotherapy will inspire future generations of scientists. His ongoing efforts to combat infectious diseases and promote healthier aging promise a lasting impact on global health and biotechnology.

Publication

  1. Title: Development of novel canine phage display-derived neutralizing monoclonal antibody fragments against rabies virus from immunized dogs
    Authors: A. Chorpunkul, U. Boonyuen, K. Limkittikul, P. Lekcharoensuk, P. Ramasoota
    Year: 2024

 

  1. Title: Characterization of Vibrio parahaemolyticus isolated from clinical specimens and oysters in Thailand
    Authors: N. Tewawong, S. Kowaboot, S. Kengkarn, P. Ramasoota, O. Suthienkul
    Year: 2024

 

  1. Title: Nicotiana benthamiana as a potential source for producing anti-dengue virus D54 neutralizing therapeutic antibody
    Authors: S. Krittanai, K. Rattanapisit, C.J.I. Bulaon, R. Strasser, W. Phoolcharoen
    Year: 2024

 

  1. Title: Associations of effort-reward imbalance at work and quality of life among workers after stroke: a one-year longitudinal study in Thailand
    Authors: S. Naknoi, J. Li, P. Ramasoota, N. Soonthornworasiri, O. Kaewboonchoo
    Year: 2023

 

  1. Title: Potential Protective Effect of Dengue NS1 Human Monoclonal Antibodies against Dengue and Zika Virus Infections
    Authors: R. Sootichote, W. Puangmanee, S. Benjathummarak, P. Ramasoota, P. Pitaksajjakul
    Year: 2023

 

  1. Title: A replication competent luciferase-secreting DENV2 reporter for sero-epidemiological surveillance of neutralizing and enhancing antibodies
    Authors: K. Saipin, B.K. Thaisomboonsuk, B. Siridechadilok, N. Sittisombut, J. Junjhon
    Year: 2022

 

  1. Title: Spread of a Novel Indian Ocean Lineage Carrying E1ā€K211E/E2ā€V264A of Chikungunya Virus East/Central/South African Genotype across the Indian Subcontinent, Southeast Asia, and Eastern Africa
    Authors: J. Phadungsombat, H.A. Imad, E.E. Nakayama, W. Piyaphanee, T. Shioda
    Year: 2022

 

šŸŽÆ Conclusion

Dr. Ramasootaā€™s work has not only advanced scientific knowledge but also contributed to real-world solutions in disease treatment and diagnostics. His collaborations with industries and commitment to innovation ensure that his research continues to benefit global health. As he continues to push the boundaries of antibody research and anti-aging science, his legacy will inspire future generations of scientists, leaving a lasting impact on virology, immunotherapy, and biotechnology.